NYT: The Moral Crisis of America's Doctors | New genetic test to reduce colonoscopies | 'We should not participate in gathering data for UHC'
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
(Becker’s GI & Endoscopy)
In 2023, there have been notable expansions by ten gastroenterology groups, increasing their presence and their footprint in the field of gastroenterology.
The providers will support the practice’s expansion in Bucks County, Pennsylvania. Of the new providers, two are physicians and two are advanced practice providers.
The AGA GI Opportunity Fund’s investment in Oshi Health is intended to improve the lives of digestive health patients by improving their access to multidisciplinary care.
The Moral Crisis of America’s Doctors?(The NY Times)
The personal accounts of physicians reveal the deep emotional impact and moral distress caused by dilemmas and ethical challenges faced by them.
(Becker’s GI & Endoscopy)
Gastroenterologist Linda Lee, MD, medical director of endoscopy at Boston-based Brigham and Women’s Hospital says that gastroenterologists should be leery of UHC’s prior authorization alternative.
Offering a blood test to people who have declined both a colonoscopy and a FIT increased colorectal cancer screening by 7.5% without decreasing use of the preferred first-line options.
The award recognizes hospitals that deliver superior patient outcomes in colorectal surgeries, gallbladder removal, upper gastrointestinal surgery, and treating bowel obstruction, gastrointestinal bleeds, and pancreatitis.
Four experts share what you need to know about the role of endoscopy in recurrent acute and chronic pancreatitis.
From AI oversight to noncompete contracts, these issues were top of mind for physician leaders at AMA's policy meeting?(Fierce Healthcare)
The article discusses the American Medical Association's (AMA) recent policy meeting where two important topics were addressed: artificial intelligence (AI) oversight and noncompete contracts for physicians.
领英推荐
Colorectal cancer: How a new genetic risk test could reduce the frequency of colonoscopies?(Medical News Today)
The article discusses a new genetic risk test that has the potential to reduce the frequency of colonoscopies in individuals at low risk for colorectal cancer.
2 Steps Are Better Than 1 for CDI Testing?(GI & Endoscopy News)
The article discusses a new algorithm developed by researchers to aid in the diagnosis and management of Clostridioides difficile infection (C. diff).
Addressing the Challenges of Gastroparesis in Patients?(GI Insights)
To discuss the challenges in diagnosing and treating gastroparesis, Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine, Pharmacology, and Physiology at the Mayo Clinic in Rochester, Minnesota.
(Medical Device Network)
Real-world data from Walgreens through the collaboration will help develop new products and services in Freenome’s multi-cancer detection research, including the blood-based screening test for colorectal cancer.
Healio covered a variety of presentations from this year’s DDW annual meeting, including the latest data on colorectal cancer, subsequent cancer diagnoses, cell-free DNA blood test for screening and the impact of aspirin and NSAID use.
The article discusses the slow adoption of endoscopic submucosal dissection (ESD) for the treatment of colorectal cancer in the United States.
$1.9 million grant awarded to explore the effect of antifungal drugs in Crohn's patients?(News Medical)
Dr. Iliyan D. Iliev, teamed up with Dr. Randy Longman, and Dr. Ellen Scherl for the study. The award will fund new research to identify Crohn's disease patients who might benefit from the antifungal therapy.
Where are physicians seeing financial losses??(Becker’s Healthcare)
According to Medscape's "Physician Wealth and Debt Report 2023," a survey of over 10,000 physicians, physicians reported various expenses and debts they were paying down.?
During the esophagus session at the AGA Postgraduate Course 2023, significant updates in esophagology were presented. Key highlights include novel care approaches for GERD, extraesophageal reflux, and Barrett's esophagus.
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the?Scope Forward newsletter.